Company Performance: GABA Therapeutics' financial health, revenue growth, profitability, and debt levels significantly impact investor confidence and stock valuation.

Drug Development Progress: Positive clinical trial results, regulatory approvals, and successful commercialization of their drug candidates boost the stock price. Delays or failures have the opposite effect.

Market Sentiment: Overall investor mood, economic conditions, and industry trends influence buying and selling pressure on GABA.ST.

Competitor Activities: Advances or setbacks by competitors in the GABAergic drug development space can affect GABA Therapeutics' perceived market position.

Regulatory Environment: Changes in regulations regarding drug approvals, pricing, and healthcare policies can impact the company's prospects.

Key Personnel Changes: Significant changes in leadership or scientific teams can create uncertainty and affect investor sentiment.

External Funding: Successful fundraising activities, such as equity offerings or partnerships, can positively impact the stock. Difficulty securing funding can negatively affect it.

Analyst Ratings: Recommendations and price targets from financial analysts can influence investor decisions.

Global Economic Conditions: Macroeconomic factors like inflation, interest rates, and economic growth can impact overall market sentiment and investment decisions.

Specific News Events: Company-specific announcements, press releases, and media coverage can cause fluctuations in the stock price.